SECTOR GAMMA AS — 13F Holdings & Portfolio
CIK 1475373 · latest 13F-HR filed 2026-08-12
SECTOR GAMMA AS manages $461.0M in 13F-reported U.S. long-equity assets across 40 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are BMY (9.08%), MRK (6.05%), MDT (5.98%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 7 new positions, exited 9, added to 22, and trimmed 9.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
P.O. BOX 462 SENTRUM
OSLO, Q8 0105
$461.0M
Long-equity book
40
Distinct positions
2026-06-30
Filed 2026-08-12
+7 / −9 / ↑22 / ↓9
vs 2026-03-31
| Name | Title / Status | Ownership | Type |
|---|
Top Adds (vs prior quarter)
- IQVIA HLDGS INC$8.2M +119.5%
- CVS HEALTH CORP$6.3M +65.3%
- CENTENE CORP DEL$5.1M +96.1%
- QIAGEN NV$4.7M +73.0%
- ABBOTT LABS$4.4M +48.9%
Top Trims
- BRISTOL-MYERS SQUIBB CO-$8.4M -16.7%
- AMGEN INC-$7.1M -42.6%
- PFIZER INC-$6.5M -21.1%
- BIOGEN INC-$4.8M -29.2%
- MERCK & CO INC-$3.4M -11.0%
New Positions
- THERMO FISHER SCIENTIFIC INC$16.8M
- REGENERON PHARMACEUTICALS$9.8M
- ASCENDIS PHARMA A/S$5.7M
- BOSTON SCIENTIFIC CORP$5.2M
- TRAVERE THERAPEUTICS INC$4.5M
Exited Positions
- UNITEDHEALTH GROUP INC$9.9M
- GILEAD SCIENCES INC$7.4M
- LANTHEUS HLDGS INC$7.1M
- ASCENDIS PHARMA A/S$4.9M
- HUMANA INC$3.3M
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | BRISTOL-MYERS SQUIBB CO | BMY | 110122108 | $41.8M | 9.08% | 726,115 | SH |
| 2 | MERCK & CO INC | MRK | 58933Y105 | $27.9M | 6.05% | 217,008 | SH |
| 3 | MEDTRONIC PLC | MDT | G5960L103 | $27.6M | 5.98% | 352,437 | SH |
| 4 | PFIZER INC | PFE | 717081103 | $24.2M | 5.25% | 1,004,215 | SH |
| 5 | INCYTE CORP | INCY | 45337C102 | $19.4M | 4.20% | 170,753 | SH |
| 6 | ELEVANCE HEALTH INC FORMERLY | ELV | 036752103 | $17.2M | 3.73% | 44,499 | SH |
| 7 | BIOMARIN PHARMACEUTICAL INC | BMRN | 09061G101 | $16.9M | 3.66% | 294,918 | SH |
| 8 | THERMO FISHER SCIENTIFIC INC | TMO | 883556102 | $16.8M | 3.65% | 33,584 | SH |
| 9 | CVS HEALTH CORP | CVS | 126650100 | $16.1M | 3.49% | 155,337 | SH |
| 10 | IQVIA HLDGS INC | IQV | 46266C105 | $15.1M | 3.27% | 77,944 | SH |
| 11 | IONIS PHARMACEUTICALS INC | IONS | 462222100 | $15.0M | 3.26% | 189,468 | SH |
| 12 | BECTON DICKINSON & CO | BDX | 075887109 | $14.1M | 3.06% | 93,168 | SH |
| 13 | ABBOTT LABS | ABT | 002824100 | $13.4M | 2.90% | 147,444 | SH |
| 14 | GE HEALTHCARE TECHNOLOGIES I | GEHC | 36266G107 | $13.3M | 2.89% | 207,863 | SH |
| 15 | ZIMMER BIOMET HOLDINGS INC | ZBH | 98956P102 | $12.3M | 2.66% | 142,307 | SH |
| 16 | BIOGEN INC | BIIB | 09062X103 | $11.7M | 2.54% | 54,163 | SH |
| 17 | QIAGEN NV | QGEN | N72482156 | $11.2M | 2.44% | 287,640 | SH |
| 18 | CENTENE CORP DEL | CNC | 15135B101 | $10.4M | 2.26% | 162,405 | SH |
| 19 | REGENERON PHARMACEUTICALS | REGN | 75886F107 | $9.8M | 2.13% | 15,780 | SH |
| 20 | BIO RAD LABS INC | BIO | 090572207 | $9.8M | 2.12% | 33,350 | SH |
| 21 | CARDINAL HEALTH INC | CAH | 14149Y108 | $9.7M | 2.10% | 40,689 | SH |
| 22 | AMGEN INC | AMGN | 031162100 | $9.5M | 2.06% | 26,281 | SH |
| 23 | BRUKER CORP | BRKR | 116794108 | $9.2M | 1.99% | 152,352 | SH |
| 24 | AVANTOR INC | AVTR | 05352A100 | $9.0M | 1.95% | 906,088 | SH |
| 25 | PTC THERAPEUTICS INC | PTCT | 69366J200 | $8.2M | 1.77% | 100,000 | SH |
| 26 | LABCORP HOLDINGS INC | LH | 504922105 | $7.3M | 1.58% | 26,019 | SH |
| 27 | DEXCOM INC | DXCM | 252131107 | $6.9M | 1.49% | 102,122 | SH |
| 28 | ASCENDIS PHARMA A/S | ASND | K08588103 | $5.7M | 1.23% | 21,305 | SH |
| 29 | EDWARDS LIFESCIENCES CORP | EW | 28176E108 | $5.5M | 1.19% | 60,402 | SH |
| 30 | SYNDAX PHARMACEUTICALS INC | SNDX | 87164F105 | $5.3M | 1.15% | 241,739 | SH |
| 31 | BOSTON SCIENTIFIC CORP | BSX | 101137107 | $5.2M | 1.12% | 121,128 | SH |
| 32 | KURA ONCOLOGY INC | KURA | 50127T109 | $4.8M | 1.03% | 433,012 | SH |
| 33 | TRAVERE THERAPEUTICS INC | TVTX | 89422G107 | $4.5M | 0.99% | 80,000 | SH |
| 34 | CRINETICS PHARMACEUTICALS IN | CRNX | 22663K107 | $4.3M | 0.93% | 114,628 | SH |
| 35 | TANDEM DIABETES CARE INC | TNDM | 875372203 | $4.0M | 0.87% | 267,091 | SH |
| 36 | IOVANCE BIOTHERAPEUTICS INC | IOVA | 462260100 | $4.0M | 0.87% | 968,466 | SH |
| 37 | CYTOKINETICS INC | CYTK | 23282W605 | $3.8M | 0.83% | 45,000 | SH |
| 38 | ORGANON & CO | OGN | 68622V106 | $3.7M | 0.80% | 270,781 | SH |
| 39 | ARDELYX INC | ARDX | 039697107 | $3.5M | 0.76% | 686,844 | SH |
| 40 | INTELLIA THERAPEUTICS INC | NTLA | 45826J105 | $3.1M | 0.68% | 185,177 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-06-30 | 2026-08-12 | $461.0M | 40 | 0000945621-26-001027 |
| 2026-03-31 | 2026-05-07 | $423.5M | 42 | 0000945621-26-000644 |
| 2025-12-31 | 2026-02-12 | $438.7M | 36 | 0000945621-26-000283 |